Mechanisms of Phase Changes in Energy Metabolism at Adaptation to Immobilization Stress: Role of Corticosterone

Author(s):  
Volodymyr I. Portnichenko ◽  
Valentina I. Nosar ◽  
Olga A. Gonchar ◽  
Anna V. Opanasenko ◽  
Irina N. Mankovskaya
2014 ◽  
Vol 60 (5) ◽  
pp. 23-32
Author(s):  
VI Portnichenko ◽  
◽  
VI Nosar ◽  
OO Honchar ◽  
HV Opanasenko ◽  
...  

Author(s):  
W.A. Jacob ◽  
R. Hertsens ◽  
A. Van Bogaert ◽  
M. De Smet

In the past most studies of the control of energy metabolism focus on the role of the phosphorylation potential ATP/ADP.Pi on the regulation of respiration. Studies using NMR techniques have demonstrated that the concentrations of these compounds for oxidation phosphorylation do not change appreciably throughout the cardiac cycle and during increases in cardiac work. Hence regulation of energy production by calcium ions, present in the mitochondrial matrix, has been the object of a number of recent studies.Three exclusively intramitochondnal dehydrogenases are key enzymes for the regulation of oxidative metabolism. They are activated by calcium ions in the low micromolar range. Since, however, earlier estimates of the intramitochondnal calcium, based on equilibrium thermodynamic considerations, were in the millimolar range, a physiological correlation was not evident. The introduction of calcium-sensitive probes fura-2 and indo-1 made monitoring of free calcium during changing energy metabolism possible. These studies were performed on isolated mitochondria and extrapolation to the in vivo situation is more or less speculative.


2019 ◽  
Author(s):  
Min Pi ◽  
Fuyi Xu ◽  
Ruisong Ye ◽  
Satoru K. Nishimoto ◽  
Robert A. Kesterson ◽  
...  

Antioxidants ◽  
2021 ◽  
Vol 10 (4) ◽  
pp. 608
Author(s):  
Domenico Nuzzo

All cells continuously generate reactive oxygen species (ROS) through the respiratory chain during the energy metabolism process [...]


1998 ◽  
Vol 275 (5) ◽  
pp. R1461-R1467 ◽  
Author(s):  
Tetsuya Ando ◽  
Jean Rivier ◽  
Hitoshi Yanaihara ◽  
Akira Arimura

We previously reported the elevation of plasma interleukin (IL)-6 activity in response to immobilization stress in rats. To investigate the role of peripheral corticotropin-releasing factor (CRF) in this response, we examined the effects of CRF antagonists on immobilization-induced IL-6 response. Intravenous pretreatment with either [d-Phe12,Nle21,38,CαMeLeu37]-anti-human rat (h/r) CRF12—41(1.5 mg/kg) or cyclo(30—33)[d-Phe12, Nle21,38,Glu30,Lys33]-h/rCRF12—41(Astressin, 0.5 mg/kg) attenuated the IL-6 response to immobilization, which confirmed our previous finding that systemic administration of an antiserum against CRF blocked this response. In addition, an intraperitoneal injection of h/rCRF (100 μg/kg) or rat urocortin (10 and 100 μg/kg) increased the plasma IL-6 activity, mimicking the response to immobilization. An intravenous injection of h/rCRF (100 μg/kg) also elevated plasma IL-6 in adrenalectomized rats. These findings suggest that peripheral CRF mediates the plasma IL-6 elevation in response to immobilization.


1979 ◽  
Vol 65 (6) ◽  
pp. 833 ◽  
Author(s):  
D. Michael Payne ◽  
David G. Powley ◽  
Ben G. Harris

2004 ◽  
Vol 36 (4) ◽  
pp. 252-261 ◽  
Author(s):  
Yi‐Hao Yu ◽  
Henry Ginsberg
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document